Suppr超能文献

内镜下全层切除术治疗胃黏膜下肿瘤:系统评价和荟萃分析。

Exposed endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors: A systematic review and pooled analysis.

机构信息

Digestive Endoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS - ISMETT Palermo, Italy.

Department of Gastroenterology and Digestive Endoscopy, AORN "Antonio Cardarelli", Napoli, Italy.

出版信息

Dig Liver Dis. 2022 Jun;54(6):729-736. doi: 10.1016/j.dld.2021.09.014. Epub 2021 Oct 13.

Abstract

BACKGROUND

Exposed endoscopic full-thickness resection (Eo-EFTR) is emerging as a promising minimally invasive alternative to surgery for the treatment of deep gastric submucosal tumors (G-SMTs). However, literature concerning this subject is heterogeneous and data mostly come from relatively small retrospective studies.

AIMS

We aimed to perform a pooled analysis of published data with regard to gastric Eo-EFTR, providing a pooled estimate of technical and clinical outcomes.

METHODS

The protocol was registered in PROSPERO. MEDLINE and EMBASE databases were searched for studies published from 1998 to 2020. The primary outcomes were complete resection and surgical conversion rates. The secondary outcomes were overall and selected major adverse events rates. The Forest plots on primary and secondary endpoints were produced based on fixed and random effect models.

RESULTS

Nineteen studies including 952 Eo-EFTR-treated G-SMTs were included. The pooled estimate of the complete resection rate and surgical conversion rates was 99.3% and 0.09%, respectively. The pooled estimate of overall major adverse events, delayed bleeding, delayed perforation and peritonitis, abdominal abscess and/or abdominal infection was 0.29%, 0.14%, 0.14%, and 0.12%, respectively.

CONCLUSION

Gastric Eo-EFTR has a high rate of complete resection with a low surgical conversion rate. It appears to be relatively safe and might represent a non-inferior minimally invasive alternative to surgery in selected cases.

摘要

背景

暴露式内镜全层切除术(Eo-EFTR)作为一种有前途的微创治疗方法,正在取代手术,用于治疗深部胃黏膜下肿瘤(G-SMT)。然而,该领域的文献存在异质性,且数据主要来自相对较小的回顾性研究。

目的

我们旨在对已发表的关于胃 Eo-EFTR 的数据进行汇总分析,提供技术和临床结果的汇总估计值。

方法

该方案已在 PROSPERO 中注册。检索了 1998 年至 2020 年期间发表的 MEDLINE 和 EMBASE 数据库中的研究。主要结局为完全切除率和手术转化率。次要结局为总不良事件发生率和选定的主要不良事件发生率。基于固定效应模型和随机效应模型生成了主要和次要结局的森林图。

结果

共纳入了 19 项研究,包括 952 例接受 Eo-EFTR 治疗的 G-SMT。完全切除率和手术转化率的汇总估计值分别为 99.3%和 0.09%。总不良事件、迟发性出血、迟发性穿孔和腹膜炎、腹部脓肿和/或腹部感染的汇总估计值分别为 0.29%、0.14%、0.14%和 0.12%。

结论

胃 Eo-EFTR 的完全切除率较高,手术转化率较低。它似乎相对安全,在某些情况下可能代表一种非劣效的微创替代手术方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验